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Abstract
The population-attributable fraction (PAF) is a popular epidemiolog-
ical measure for the burden of a harmful exposure within a population.
It is often interpreted causally as proportion of preventable cases after an
elimination of exposure. Originally, the PAF has been defined for cohort
studies of fixed length with a baseline exposure or cross-sectional studies.
An extension of the definition to complex time-to-event data is not
straightforward. We revise the proposed approaches in literature and pro-
vide a clear concept of the PAF for these data situations. The concep-
tualization is achieved by a proper differentiation between estimands and
estimators as well as causal effect measures and measures of association.
keywords:Causal effect measure, Competing risks, Excess fraction,
Measure of association, Nosocomial infection, Time-dependent exposure
1 Introduction
A relevant statistical quantity in epidemiology is the population-attributable
fraction (PAF). Initially, the PAF has been defined for cross-sectional studies
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and cohort studies of fixed length with a baseline exposure. It summarizes the
population-attributable burden by taking both the relative risk (RR) of exposure
and the prevalence into account. Provided adequate consideration of confounding
the PAF is interpretable as a causal effect measure and quantifies the benefit of
a preventive intervention against a harmful exposure.
However, in hospital epidemiology researchers are confronted with complex
time-to-event data. To study, for example, the burden of hospital-acquired in-
fections (HAIs) in terms of intensive care mortality, one has to account for the
time-dependency of an acquisition of HAIs. All patients are naturally unexposed
at intensive care unit (ICU) admission. Then, an infection may occur over the
course of the ICU stay of the patients.
Additionally, discharge alive is a competing event to death in the ICU. Dis-
regarding the competing risk by e.g. censoring discharged patients can lead to a
strong overestimation of ICU mortality ([1]).
The PAF being interpreted as proportion of preventable cases is commonly
considered as causal effect measure ([2]). Causal modelling of the effect of a
harmful time-dependent exposure is challenging. For example, the different times
of onset of the infection give rise to a high range of possible exposure paths. These
are additionally complicated by the competing risks setting resulting in varying
lengths of ICU stays and therefore varying lengths of follow-up.
Literature provides two different approaches to obtain the PAF for time-
dependent exposures and competing outcomes. However, an extension of the
PAF to a time-dependent setting is not straightforward. This article is devoted
to a comprehensive revision of the literature on the PAF for complex time-to-
event data arising in hospital epidemiology.
In Section 2, we review the definition of the PAF based on the extended
illness-death model as proposed by [3]. The definition is an extension of the
time-independent estimand of the PAF provided by [4]. Statistical nomenclature
allows for a differentiation between measures of association and causal effect
measures. In this sense, [4] defined the PAF as measure of association that is
based on observable quantities.
Section 3 is meant to view the PAF for time-varying exposures from a causal
perspective. Causal effect measures can be defined by counterfactual outcomes.
Such an approach has been proposed by [5]. Motivated by their work, we define
an estimand that is a natural extension of the time-independent definition of
the PAF as proposed by [6]. In contrast to [4], [6] provides an estimand of
the PAF that is based on counterfactual outcomes. Nonetheless, in the absence
of confounding the time-independent definitions of the PAF by [6] and [4] are
equivalent ([7]). For identification of our proposed estimand, we use the same
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multi-state model as [3]. The multi-state model approach allows for a direct
comparison of the two time-dependent estimands of the PAF.
Such a comparison is performed in Section 4. We explain the difference be-
tween the two approaches and provide a framework which allows for a proper
interpretation of both of the estimands.
Then, based on this conceptualization of the two estimands, we revise the
estimation procedures of the PAF as outlined by [5]. This is done in Section
5 by showing mathematically the proper use of their estimators. Finally, the
approaches are applied to a sample of ICU patients to estimate the burden of
hospital-acquired pneumonia (HAP). The data example illustrates the practical
behaviour of the estimands and explains the interpretation based on a real data
example. The article ends with a discussion.
2 The PAF for time-dependent exposures and
competing risks - defined with observable vari-
ables
[4] defined the PAF for cohort studies of fixed length with a baseline exposure
and cross-sectional studies as
PAFo =
P (D = 1)− P (D = 1|E = 0)
P (D = 1)
, (1)
where E indicates whether the patient was exposed (for example infected) and D
indicates whether the patient experienced the outcome of interest (for example
death in the ICU). This definition is based on observable random variables of
exposure and outcome. Defined as measure of association, PAFo is interpretable
as the proportion of attributable cases observed in association with exposure.
In the absence of confounding it can be also interpreted as proportion of pre-
ventable cases if exposure was eliminated for all patients ([8]). The index ’o’ in
the definition denotes that PAFo is defined with observable quantities.
In the following, we refer to cross-sectional studies and cohort studies of fixed
length with a baseline exposure as ’time-fixed’ data settings.
2.1 The estimand PAFo(t)
[3] extended the definition of the PAF proposed by [4] to account for the time-
dependency of exposure and outcome. As [3], we use the example of HAIs to
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define the estimand. Nevertheless, it is applicable to any data situation with
binary time-dependent exposure. The estimand PAFo(t) is formally given by
PAFo(t) =
P (D(t) = 1)− P (D(t) = 1|E(t) = 0)
P (D(t) = 1)
, (2)
where D(t) indicates if the patient died in the ICU by time t and E(t) if the
patient acquired the exposure (i.e. an HAI) by time t. Both E(t) and D(t) are
observable random variables. The variable D(t) is equal to one if the patient was
observed to die in the ICU by time t. Otherwise, if the patient was still alive at
time t (either discharged alive by t or still in the ICU), then D(t) = 0. Thus,
P (D(t) = 1) is the overall ICU mortality risk in the patient population.
The death risk among unexposed, P (D(t) = 1|E(t) = 0), is defined as a
specific version of the conditional probability function (CPF) of [9]. At each
time point t the unexposed patients are defined to be those patients that did
not acquire an infection until t. Therefore, they are an observable time-varying
subpopulation of the reference population. The CPF has been initially proposed
as a summary measure for the probability of a certain outcome in the presence of
competing risks. Considering the data example of HAIs, it is interpretable as the
probability of death in the ICU by time t given the patient remained uninfected
until t. As discussed by [9] and [10], the CPF is neither a predictive nor a causal
quantity. Being based on observable quantities, PAFo(t) is defined as a measure
of association. PAFo(t) relates the proportion of patients that acquired an HAI
by time t with that of the patients who remained HAI-free until time t.
0: Admission
to the ICU 1: HAI
2: Discharge 
(without HAI)
3: Death 
(without HAI)
4: Discharge 
(with HAI)
5: Death 
(with HAI)
α03( t)
α01(t)
α14(t ) α15(t)α02(t )
Figure 1: Extended illness-death model with hazard rates α01(t), α02(t), α03(t),
α14(t) and α15(t).
As we regard only infections acquired in the hospital or ICU, all patients are
free of HAI at the beginning of the study. This implies that E(0) = 0 for all
patients. Nonetheless, a relaxation of this property is straightforward and has no
influence on the conclusions we are drawing.
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2.1.1 Estimation of PAFo(t)
The estimand PAFo(t) can be identified with the transition probabilities of the
extended illness-death model ([3]) shown in Figure 1. This model has the initial
state ’Admission to the ICU’ and accounts for HAI-acquisition as an intermediate
state. Discharge alive from the ICU is a competing risk to death in the ICU. These
two absorbing states are modelled both before and after HAI-acquisition. The
risk of death at time t among unexposed patients at t is defined by
P (D(t) = 1|E(t) = 0) = P03(0, t)
P00(0, t) + P02(0, t) + P03(0, t)
(3)
=
P03(0, t)
1− (P01(0, t) + P04(0, t) + P05(0, t)) ,
where P0l(0, t) (l = 0, 2, 3) denote the transition probabilities of the extended
illness-death model. This quantity is referred to as CPF ([9]). More explicitly,
the transition probabilities are defined as
P00(0, t) = exp
(
−
∫ t
0
α01(u) + α02(u) + α03(u) du
)
= exp
(
−
∫ t
0
α0(u) du
)
,
P02(0, t) =
∫ t
0
P00(0, u)α02(u) du, (4)
P03(0, t) =
∫ t
0
P00(0, u)α03(u) du,
where αkl(t), k = 0, 1, l = 1, 2, 3, 4, 5, are the cause-specific hazard rates of the
extended illness-death model and α0(t) = α01(t) + α02(t) + α03(t). In contrast to
the marginal probability P03(0, t), the conditional probability P (D(t) = 1|E(t) =
0) (3) conditions on the additional information that patients remained infection-
free until time t.
The overall ICU death risk is identified by
P (D(t) = 1) = P03(0, t) + P05(0, t), (5)
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with P05(0, t) being explicitly defined as
P05(0, t) =
∫ t
0
P00(0, u)α01(u)P15(u, t) du, (6)
P15(0, t) =
∫ t
0
P11(0, u)α15(u) du, (7)
P11(0, t) = exp
(
−
∫ t
0
α14(u) + α15(u) du
)
.
Therefore, P (D(t) = 1) depends on all five hazard rates of the extended
illness-death model. The death risk among unexposed, P (D(t) = 1|E(t) = 0),
depends on the death and discharge hazard without an HAI as well as on the
infection hazard.
Estimation of PAFo(t) is based on the Aalen-Johansen estimators of the
transition probabilities of the extended illness-death model. For details, we
refer to [11] and [3]. When using the Aalen-Johansen estimators for P0l(0, t)
(l = 0, 2, 3, 5), the Markov assumption is assumed to be plausible. For the ex-
tended illness-death model, the Markov assumption means that the risk of death
and discharge given an HAI depends only on the total length of stay in the hos-
pital and not on the length of stay in the hospital until acquisition of an HAI.
The plausibility of this assumption can be tested by including time of acquisition
of an HAI as covariate in a Cox proportional hazards model for the transitions
from State 1 to States 4 and 5 ([12]).
Nevertheless, PAFo(t) can be estimated without having to make this assump-
tion. The overall mortality risk P (D(t) = 1) can be equivalently identified by a
competing risks model in which States 2 and 4 and States 3 and 5 are combined.
The resulting model does not differentiate between infected and uninfected pa-
tients but validly models overall ICU mortality. In competing risks models, the
Markov assumption is naturally avoided ([11]).
The death risk among unexposed, P (D(t) = 1|E(t) = 0), can be estimated
by a three-states competing risks model which results from Figure 1 by dropping
States 4 and 5. With this model, P (D(t) = 1|E(t) = 0) can be identified since
P03(0, t) is independent of the events past exposure acquisition and the sum
P01(0, t) +P04(0, t) +P05(0, t) is equal to the cumulative incidence function (CIF)
of acquiring an HAI. Both of these probabilities can be identified and estimated
with a competing risks model. For more details, we also refer to the appendix.
An adjusted PAFo(t) can be obtained either by stratification based on baseline
covariates or by using a semi-parametric model as proposed by [13]. For the
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estimation of 95% confidence intervals (CIs) we suggest to use a bootstrap method
([14]).
3 The PAF for time-dependent exposures and
competing risks - defined with counterfactual
variables
The PAF as a causal effect measure for time-fixed data settings has been defined
by [6] as
PAFc =
P (D = 1)− P (D0 = 1)
P (D = 1)
, (8)
where P (D = 1) is the observable risk of the outcome and P (D0 = 1) the hypo-
thetical risk had the patients remained – possibly contrary to fact – unexposed.
PAFc is interpretable as the proportion of preventable cases if exposure was
eliminated for all patients. In the absence of confounding PAFc and PAFo are
equivalent ([7]). The index ’c’ in the definition of PAFc refers to the counterfac-
tual nature of the estimand.
3.1 The estimand PAFc(t)
In Section 2, the PAF has been identified using a multi-state model that accounted
for infection as competing event to death without infection. This approach was
based on observable quantities which are commonly used to make predictions.
Yet, the PAF is most often interpreted as a causal effect measure ([2]). Con-
sidering our data example it aims at answering the question of how many death
cases occurring in the ICU would be spared if an intervention prevented HAIs.
[5] proposed to use causal inference to estimate the PAF. We formalize their
approach and define the estimand with the desired interpretation by
PAFc(t) =
P (D(t) = 1)− P (D0(t) = 1)
P (D(t) = 1)
, (9)
where D(t) is defined in the same way as in Section 2, namely as the observable
random variable of death by time t. The variable D0(t) is the counterfactual
outcome at t had the patient been (possibly contrary to fact) unexposed until time
t. Thus, P (D0(t) = 1) is the hypothetical death risk at t had all patients remained
unexposed until time t or the end of their ICU stay, whichever comes first. This
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definition of the PAF compares the same patient population under two distinct
conditions, namely the population as it is actually observed compared to the
same population in a world without infections. Hence, PAFc(t) is interpretable
as proportion of preventable cases if exposure was extinct.
3.1.1 Estimation of PAFc(t) using a multi-state model
We use the extended illness-death model in Figure 1 to identify PAFc(t). The
overall mortality risk, P (D(t) = 1), is the same statistical quantity as in the
definition of PAFo(t). Therefore, it can be identified in the same way as explained
in Section 2.
The hypothetical death risk had all patients remained unexposed until time
t or the end of their ICU stay, P (D0(t) = 1), can be identified with the extended
illness-death model by setting the infection hazard to zero. The resulting model
is a competing risks model with the two states death and discharge without an
HAI (see Figure 2). Then, P (D0(t) = 1) is identified by the CIF of death without
an HAI. We denote the transition probabilities of this model with P0l0(0, t), l =
0, 2, 3. They are explicitly given by
P000(0, t) = exp
(
−
∫ t
0
α02(u) + α03(u) du
)
,
P020(0, t) =
∫ t
0
P000(0, u)α02(u) du, (10)
P030(0, t) =
∫ t
0
P000(0, u)α03(u) du.
The estimands P0l0(0, t), l = 0, 2, 3, are independent of the infection hazard.
An estimator of P030(0, t) is for example the Aalen-Johansen estimator in
the competing risks model (Figure 2). In contrast to the transition probabil-
ity P03(0, t) obtained from the extended illness-death model (Figure 1), patients
acquiring an infection are treated as censored observations. We denote the Aalen-
Johansen estimator of P (D0(t) = 1) by Pˆ030(0, t).
The proposed estimation procedure for PAFc(t) makes use of an inference
technique for competing risks which results by assuming equivalence of a com-
peting risk and independent censoring. More precisely, independent censoring
means that the cause-specific hazard rates remain undisturbed by censoring ([15]).
Generally, it is strongly disadvised to handle competing risks as independently
censored events (e.g. [11, 15, 16]). Even if the assumption of independence is
justified, the estimands that result from this estimation procedure are considered
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to have a questionable interpretation (see e.g. [11, 15, 16]). Nevertheless, they
appear to be useful for defining and estimating the PAF: The population param-
eters, P0l0(s, t), l = 0, 2, 3, are meant to be derived for the same population as
the estimands P0l(s, t), l = 0, 2, 3. However, they have a different interpretation.
While P03(s, t) is the risk of death by time t without an HAI, P030(s, t) is the
risk of death by time t if HAIs were prevented. Thus, P03(s, t) is a probability of
factual events, while P030(s, t) is a probability of hypothetical ones. Censoring a
competing risk allows for an investigation of hypothetical scenarios ([17]).
In our setting the independent censoring assumption translates into assuming
that patients who acquired an HAI are under the same risk of death and dis-
charge as patients who are still infection-free in the ICU. Hence, the proposed
estimator is unbiased if patients that remain infection-free are representative of
all patients. This assumption is called exchangeability assumption. In an ob-
servational study, it is highly unlikely that exposed and unexposed patients are
exchangeable. Therefore, the estimator must be adjusted for confounding. Due
to the time-dependency of exposure confounding is generally time-varying as well
and feedback between the confounders and exposure is to be expected ([18]). Ad-
justment for such confounding can be done by using inverse-probability weights
([19]). [5] provide a method which allows for adjustment for confounding of
PAFc(t) in a time-discrete approach. This methodology is discussed in more de-
tail in Section 5. Moreover, [5] shortly discuss the assumptions of consistency and
positivity which are fundamental to identify causally interpreted effect measures
from observational data (see also the appendix). A more detailed definition of
these assumptions is provided by [20]. For estimation of the 95%-CIs, we propose
to use a bootstrap approach ([14]).
4 Conceptualization of PAFo(t) and PAFc(t)
Both PAFo(t) and PAFc(t) extend the time-independent definition of the PAF.
PAFo(t) is defined by observable quantities and is an extension of the definition
provided by [4]. In contrast, PAFc(t) is defined with counterfactuals and extends
the definition by [6].
In the time-fixed data setting, we can achieve – under certain assumptions –
equivalence of PAFo and PAFc ([7]). In fact, the causally defined effect measure
PAFc is identifiable only if P̂AF o has a causal interpretation. Then, P̂AF o
estimates PAFc. For a detailed explanation under which conditions PAFc is
identifiable, we refer to [6] .
Comparing PAFo(t) and PAFc(t), we find that this basic relation of causal
effect measures and measures defined as associational quantities no longer holds
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0: Admission
to the ICU
Randomly 
censored
2: Discharge 
(without HAI)
3: Death 
(without HAI)
α03( t)α02(t )
Figure 2: The competing risks model with cause-specific hazard rates α02(t),
α03(t). In contrast to Figure 5 in the appendix, patients that acquire an HAI are
randomly censored with censoring rate α01(t). The event ’Acquisition of HAI’ is
not being considered.
in this way if exposure depends on time. While the factual overall mortality
risk in the population, P (D(t) = 1), is the same in both definitions, the two
estimands, PAFo(t) and PAFc(t), differ in the definition of the death risk among
unexposed patients. First, we note that generally
P (D0(t) = 1) 6= P (D(t) = 1|E(t) = 0).
Even in the absence of confounding, the death risk in the subpopulation of
patients that were observed to be unexposed until time t, P (D(t) = 1|E(t) = 0),
is not the same as that in the hypothetical population in which all patients would
have remained unexposed until t, P (D0(t) = 1). This is in contrast to the time-
fixed situation, where these two quantities are indeed the same.
[21] explain the difference between explanatory modelling which aims at un-
derstanding causal relations and descriptive modelling which aims at summarizing
the data structure and illustrating basic associations. Based on this conception
of statistical modelling, we now provide a clear concept of the two estimands and
their correct interpretation.
When taking the causal point of view, the goal is explanatory modelling
of the PAF. The PAF interpreted as a causal effect measure (i.e. proportion
of preventable cases, PAFc(t)) aims to compare the factual patient population
with a hypothetical one had all patients remained unexposed. However, the
subpopulation of patients observed to be unexposed at time t (patients with
(E(t) = 0)) is not a sample of this hypothetical population. This is even the case
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in the absence of confounding.
More precisely, the estimand P (D(t) = 1|E(t) = 0) is structurally biased
from a causal perspective. The bias arises by conditioning on E(t) = 0. By
assessing the infection state specifically at t while allowing for death within (0, t],
we condition upon having reached an absorbing state thereby creating selection
bias ([10]). The condition E(t) = 0 translates into the condition of being in either
State 0, 2 or 3, where States 2 and 3 are absorbing.
In other words, the hypothetical intervention that could prevent exposure
is ill-defined. As a consequence, the estimand PAFo(t) is not interpretable as a
causal effect measure. Hence, in contrast to PAFc(t), PAFo(t) is not interpretable
as proportion of preventable cases if a hypothetical intervention eliminated ex-
posure, even in the absence of confounding.
Thus, on the one hand, PAFo(t) extends the time-fixed definition of [4] as a
basic relation of the proportion of cases. On the other hand, it is not an extension
of the PAF as a causal effect measure.
When taking the observational point of view the goal is descriptive mod-
elling of the PAF. PAFc(t) is not a summary measure for the factual accumulation
of attributable death cases associated with exposure. For example, HAIs occur
over the course of time and are by definition not present at baseline. As a con-
sequence, death cases accumulate first among unexposed and with a time-delay
among exposed patients. While the time-delay is not a causal consequence of
HAIs, it remains a natural characteristic that comes along with HAIs. For a
proper understanding of the timing of exposure and outcome, the time of in-
fection should be accounted for. PAFc(t) depends only indirectly on the time
of infection via P (D(t) = 1). However, the intensity of HAI acquisition is not
captured.
5 Conceptualization of estimators for PAFo(t)
and PAFc(t)
The failure to properly distinguish these two effect measures has caused miscon-
ceptions in literature. In the following, we clarify these misconceptions by proving
that the two estimation procedures proposed by [5] lead to the estimation of two
different estimands, namely PAFo(t) and PAFc(t).
First, we introduce the estimation procedure proposed by [5]. They provide
two estimators of the PAF based on estimated CIFs. As discussed in Section 4,
the difference between PAFo(t) and PAFc(t) is via the definition of the death
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risk among unexposed. The observable overall mortality risk is equivalent in all
approaches.
[5] denote the (estimated) death risk among unexposed by Fˆ01(t) and define
it as the ”estimated counterfactual CIF of ICU mortality at time t under the
no-infection path” ([5]). The no-infection path implies that the patient remained
– possibly contrary to fact – infection-free during the complete follow-up time
(0, τ ]. The no-infection path is equivalent to assuming that the patient remained
unexposed until the end of their ICU stay. For a detailed explanation of the
hypothetical infection paths we refer to [5]. To properly differentiate between
estimands and estimators, we denote the counterfactual CIF of ICU mortality at
time t under the no-infection path by F01(t).
[5] refer to the unadjusted version of their estimated PAF as naive, since it is
not adjusted for confounding. This estimator is given by
F̂ naive01 (t) :=
∑t
s=1 d01s
n0t
=
∑n
i=1 1(i(t) = 1)
∏t
s=1(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0))∑n
i=1
∏t
s=1(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0))
,
where n is the total number of sampled patients in the study, i(t) is the observable
outcome of patient i at time t with i(t) = 1 if the patient i died in the ICU by
time t, i(t) = 2 if the patient was discharged alive by t and i(t) = 0 if the patient
was still in the ICU. The quantity Ai(t) is an indicator of the observed infection
state of patient i at time t. We denote the estimator of the PAF resulting from
using F̂ naive
01
(t) as ”estimated counterfactual CIF of ICU mortality at time t under
the no-infection path” by P̂AF
naive
B (t).
Bekaert et al. propose to adjust for confounding by adjusting F̂ naive
01
(t) using
inverse-probability of exposure weights (IPWs). This estimator is formally given
by
Fˆ IPW01 (t) =
∑n
i=1 1(i(t) = 1)Wi0t∑n
i=1Wi0t
,
with
Wi0t =
t∏
s=1
(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0)
P (Ai(s) = 0|(i(s− 1), Ai(s− 1)) .
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We denote the estimator of the PAF that results from using Fˆ IPW
01
(t) as the
”estimated counterfactual CIF of ICU mortality at time t under the no-infection
path” by P̂AF
IPW
B (t).
5.1 Properties of P̂AF
naive
B (t) and P̂AF
IPW
B (t)
To investigate the estimation procedure of the PAF proposed by [5] more closely,
we first consider F̂ naive
01
(t) =
∑t
s=1 d01s
n0t
.
Without censoring, the number of patients that are observed to be unexposed
until time t are those that were discharged alive or died without an HAI within
(0, t] and those that are still at risk and uninfected at t. For each of these patients
– an individual patient is denoted by i – we have
t∏
s=1
(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0)) = 1
for t ≤ τ . Otherwise, if the patient acquired an infection any time before or at t,
the product for this patient is equal to zero. Thus,
n0t =
n∑
i=1
t∏
s=1
(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0))
= # of patients observed to be unexposed until t
Equivalently, we have for the numerator that
t∑
s=1
d01s =
n∑
i=1
1(i(t) = 1)
t∏
s=1
(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0))
= # of patients observed to have died without HAI by time t.
Thus, F̂ naive
01
(t) is the proportion of patients that died without exposure by
time t among those that remained unexposed until time t.
Without independent censoring, the estimated death risk among unexposed
of PAFo(t), P̂ (D(t) = 1|E(t) = 0), is also simply the proportion of patients that
died without exposure by time t among those that remained unexposed until t
([22]).
Therefore,
P̂ (D(t) = 1|E(t) = 0) = F̂ naive01 (t)
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having as direct consequence that
P̂AF o(t) = P̂AF
naive
B (t).
In the appendix, we provide a detailed proof of P̂AF
naive
B (t) estimating PAFo(t).
The proof is based on showing that F̂ naive
01
(t) = P̂ (D(t) = 1|E(t) = 0).
Moreover, we proof in the appendix that the use of the weighted estimator
Fˆ IPW
01
(t) results in an estimator of PAFc(t). In the absence of confounding, we
have that
Fˆ IPW01 (t) = Pˆ030(t).
The proof is based on showing that the Fˆ IPW
01
(t) is equivalent to a Horvitz-
Thompson like estimator of the CIF. However, instead of weights that are the
inverse of the probability of being randomly censored, the weights are the inverse
probability of exposure weights. Thus, patients that acquire an HAI are treated
in the same way as if they were randomly censored. This shows that Fˆ IPW
01
(t) =
Pˆ030(t) and therefore
P̂AF c(t) = P̂AF
IPW
B (t).
Hence, even in the absence of confounding, we generally have
P̂AF
naive
B (t) 6= P̂AF
IPW
B (t).
This implies especially that P̂AF
naive
B (t) and P̂AF
IPW
B (t) differ in interpreta-
tion. The two estimators estimate two distinct statistical quantities. The unad-
justed version, P̂AF
naive
B (t), is an estimator of PAFo(t). The adjusted version,
P̂AF
IPW
B (t), is an estimator of PAFc(t) even in the absence of confounding. We
highlight that the difference between P̂AF
naive
B (t) and P̂AF
IPW
B (t) is not solely
due to confounding as explained by [5].
In Table 1, we summarize the estimands and according estimators.
6 Data example
In this section, we study the PAF of hospital-acquired pneumonia (HAP). We
estimate PAFc(t) to quantify the benefit of an intervention that could prevent
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Estimand Modelling Interpretation Estimator
intention
PAFo(t) = Descriptive Proportion of P̂AF o(t),
P (D(t)=1)−P (D(t)=1|E(t)=0)
P (D(t)=1)
observable attributable P̂AF
naive
B (t)
cases accumulated
up to time t
PAFc(t) = Causal/explanatory Proportion of P̂AF c(t),
P (D(t)=1)−P (D0(t)=1)
P (D(t)=1)
preventable cases P̂AF
IPW
B (t)
up to time t
P (D(t) = 1|E(t) = 0) Descriptive Proportion of cases until t Pˆ03(t)
Pˆ00(t)+Pˆ02(t)+Pˆ03(t)
,
among unexposed at t F̂ naive
01
(t)
P (D0(t) = 1) Causal/explanatory Hypothetical proportion Pˆ030(t),F̂
IPW
01
(t)
of cases until t
had all patients
remained unexposed
Table 1: The various estimators of PAFo(t), PAFc(t), P (D(t) = 1|E(t) = 0) and
P (D0(t) = 1).
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HAP for all patients admitted to the ICU during their complete ICU stay. More-
over, we estimate PAFo(t) to understand the population-attributable burden of
HAP. It provides an explanation for clinicians about how death cases accumulate
over the course of time among uninfected patients in relation to the number of
cases occurring among all patients. PAFo(t) summarizes what clinicians see on
their daily routine.
The data is a sample of the SIR-3 (Spread of nosocomial Infection and Re-
sistant pathogens) study (see [23]) and similar to the data example of [3]. The
SIR-3 sample is publicly available in the R-package kmi ([24]). It consists of 1313
patients of whom 108 eventually acquired a HAP. Of the patients who remained
free of HAP 126 died in the ICU and 1062 were discharged alive. Seventeen pa-
tients were censored before acquiring a HAP. Of the patients who were observed
to be infected, 21 died in the ICU, 82 were discharged alive and 22 were lost to
follow-up. The one patient who remained for more than 100 days in the ICU was
administratively censored after 100 days. We first studied the effect of HAP on
the death and discharge rates by considering HAP as a time-dependent covariate
in a Cox proportional hazards model (Cox PH model). As typically found in
the study of HAIs in ICUs in Europe, see e.g. [11] and [25], there was no direct
effect of HAP on the death hazard (HR=0.99; 95%-CI [0.61; 1.60]). However, the
discharge hazard was significantly decreased for patients with HAP (HR=0.61;
95%-CI [0.48; 0.76]). As discussed by e.g. [25], this means that patients with
HAP stay longer in the ICU and therefore longer at risk to die in the ICU.
To understand the burden of HAP on a population level and the benefit
of a preventive intervention, we estimate both PAFo(t) and PAFc(t) using the
described methods. The result is shown in Figure 3. Adjustment for the available
time-independent covariates age and gender did not alter the estimators in a
mentionable way.
Both, P̂AF c(t) and P̂AF o(t) vary around zero within the first 20 days since
ICU admission. Then, both continuously increase.
After 100 days P̂AF o(t) is 0.073 explaining that 7.3% or respectively 11 death
cases out of all death cases that occurred by then were observed to be excess in
association with HAP.
The proportion of preventable cases after 100 days, P̂AF c(100), is 0.055. This
corresponds to 8 preventable cases if an intervention eliminated HAP during the
complete ICU stay of the patients or up to 100 days, whichever occurred first.
In this data sample, P̂AF o(t) becomes greater than P̂AF c(t) for larger t. This
is not generally the case. In a recently submitted manuscript ([26]) we studied
various simulated scenarios to investigate the behaviour of PAFo(t) and PAFc(t).
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Figure 3: P̂AF o(t) and P̂AF c(t) of HAP for a sample of 1313 patients of the
SIR-3 study.
A typical scenario in which PAFo(t) is greater than PAFc(t) is a setting, where
the discharge hazard without HAP is large in the beginning and then decreases
while at the same time, the death hazard without HAP increases from a low level.
Such a scenario is comparable to the hazard rates of our data sample shown in
Figure 4. While P (D0(t) = 1) depends only on the death and discharge hazards
without HAP, P (D(t) = 1|E(t) = 0) depends also on the infection hazard. The
overall death risk P (D(t) = 1) depends on all the five hazard rates.
PAFo(t) is typically below zero within the first days, as patients may already
die without a HAP while it takes some time until the first patients have acquired
a HAP to then die with it ([22]). Both P̂AF o(t) and P̂AF c(t) vary around
zero as the death hazard with HAP is slightly smaller than the death hazard
without a HAP in the first 20 days. At the same time the discharge hazard
without HAP is much larger but strongly decreasing between day 10 and 20, while
the discharge hazard with HAP increases. As P̂AF o(t) and P̂AF c(t) are both
cumulative measures, and the overall effect of HAP is harmful, both PAFB(t)
and PAFo(t) eventually continuously increase. The behaviour of P̂AF o(t) and
P̂AF c(t) demonstrates the sensitive dependence on the five hazard rates. We
remark, that the difference between Pˆ (D(t) = 1|E(t) = 0) and P (D0(t) = 1) is
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considerable small, due to the low infection hazard.
Figure 4: Cause-specific hazard rates of the sample of 1313 patients of the SIR-3
study.
7 Discussion
In this article, we revised and advanced the literature on the PAF for data settings
commonly arising in hospital epidemiology. By a mathematical exploration, we
showed that literature provides two distinct definitions which we have denoted
by PAFo(t) and PAFc(t). Definition and estimation of PAFo(t) was a revision
of the proposition by [3]. Definition of PAFc(t) was motivated by the work of
[5]. The estimation procedure, we proposed for PAFc(t) has been suggested in
a technical report by [27]. Moreover, the hypothetical manipulation of cause-
specific hazard rates in multi-state models has been also discussed by [17] and
most recently by [28].
We found that, in contrast to the PAF as effect measure for baseline expo-
sures, the proportion of attributable risk based on observable quantities cannot be
described by the same statistical measure as the proportion of preventable cases if
exposure was extinct. Based on the differentiation between explanatory, predic-
tive and descriptive statistical modelling by [21], we developed a clear concept of
the two different estimands. The former, PAFo(t), is a descriptive quantity that
serves to understand the factual burden of exposure. The latter, PAFc(t), is an
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explanatory quantity and a causal extension of the PAF for time-dependent ex-
posures. [29] described the difference between causal and conventional modelling
as the difference between seeing (descriptive point of view) and doing (causal
point of view). In this sense, we categorized PAFo(t) as ’seeing’ and PAFc(t) as
’doing’.
A prominent example which has led to a similar discussion as ours is the Cox
PH model. By conditioning on survival up to a certain time point and assuming
a time constant hazard ratio, the Cox PH model has a built-in selection bias
similar to PAFo(t) ([30]). Nevertheless, it is one of the most relevant quantities
that properly takes the temporal dynamics into account.
We used our formalization of PAFo(t) and PAFc(t) to explain misinterpreted
results found in the literature (see [5]). Yet up to now, a distinction between
causal effect measures and measures based on observable quantities is often only
discussed in terms of confounding. However, our results suggest that in the time-
dependent situation, confounding is not the crucial difference between the two
modelling strategies. By properly distinguishing between estimands and estima-
tors ([31]) and simplifying the estimation procedure for the PAF proposed by [5],
we showed that differences between adjusted and unadjusted estimates cannot
be fully explained by confounding. Instead, the differences were a consequence
of the fact that the two estimation procedures resulted in two distinct statistical
measures. Our conceptualization of the PAF clarifies which estimator is appropri-
ate for which estimand. Given that they are correctly interpreted, the estimators
proposed by [5] provide unbiased results and are an important contribution to the
field. Especially the estimator PAF IPWB (t) which we proofed to be an estimator
of PAFc(t) allows for adjustment for time-varying confounding. Such adjustment
is essential when estimating PAFc(t).
In this article, we approached the causally defined estimands of the PAF
with conventional statistical modelling by using a multi-state model approach.
Estimation of causal effects is only possible under strong and untestable assump-
tions. We mentioned the most important conditions for causal inference, namely
exchangeability, consistency, and positivity. However, we did not go into detail
and we did not formalize further conditions that might become necessary. These
include, for example, correct model specification for parametric estimators and
the assumption that the removal of exposure does not alter the distribution of
other risk factors.
Additionally to these untestable assumptions, we mentioned the Markov as-
sumption which must be made to estimate transition probabilities of multi-state
models with the Aalen-Johansen estimator. The Markov assumption facilitates
estimation of transition probabilities that involve intermediate events. For ex-
ample, to obtain a full picture of the course of infection and its consequences for
19
infected patients, all transition probabilities of the extended illness-death model
are of interest. In contrast, both estimands, PAFo(t) and PAFc(t), can be es-
timated without having to make the Markov assumption. The PAF quantifies
the burden of exposure on a population level and is not a measure for the conse-
quences of exposure among already exposed patients.
A causal approach to the estimation of population risks has been proposed by
[32]. They use the g-formula to account for a time-dependent exposure and time-
varying confounding. However, their exploration does not include data settings
with competing risks.
In practice, time-dependent exposures are common but often avoided by e.g.
summarizing data at the end of follow-up. Such data is then aggregatable in
a fourfold table of exposure and outcome and the time-fixed definition of the
PAF (1) can be used. In the absence of censoring the estimand that results
from this procedure is equal to PAFo(τ), where τ denotes the end of follow-up
([3, 22]). Therefore, our conclusions on PAFo(t) apply equally to this frequently
used approach.
More specifically, the estimand PAFo(τ) has no causal interpretation even
in the absence of confounding. The only exception is a data setting with time
constant hazards, then we have that PAFo(τ) = PAFc(τ) ([22]). Nevertheless,
PAFo(τ) summarizes PAFo(t) at the end of follow-up and therefore serves as a
description of the factually observed burden of exposure.
Other commonly used effect measures such as the RR, the RD, and the OR
defined as measures of association are also based on P (D(t) = 1|E(t) = 0).
Hence, these associational effect measures also have no causal interpretation,
even in the absence of confounding if the exposure occurs during follow-up.
Nevertheless, we provide a framework to interpret these estimands in a mean-
ingful way. For example, despite having no causal interpretation PAFo(τ) re-
mains an estimand that validly quantifies the population-attributable burden of
a harmful exposure.
Measures of association are said to be structurally biased if they differ from
their causal analogues ([33, 34]). In the time-fixed data setting, the consistency
and exchangeability assumptions are sufficient to be able to interpret measures
of association as causal effect measures or vice versa to identify an estimand
defined with counterfactual variables. ([7]). However, in time-dependent data
settings, previous exposure and outcome states influence the present states. The
timing of exposure and outcome may not be a causal consequence of exposure.
Nevertheless, time to exposure is a natural aspect of a time-dependent exposure.
The time-fixed PAF is said to be a causal quantity ([2]). With regard to
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the different interpretation of the two estimands PAFc(t) and PAFo(t), we re-
frain from generalizing this statement to the more natural time-dependent data
settings.
For example, to obtain a profound understanding of the observable population-
attributable burden and the proportion of preventable cases, both PAFo(t) and
PAFc(t) should be considered. This has been demonstrated with a publicly avail-
able data example. We estimated the population-attributable burden of HAP and
also the proportion of preventable ICU death cases if a hypothetical intervention
prevented HAP for all patients during their complete ICU stays.
Our results show that the timing of exposure acquisition contradicts causal in-
terpretation of unconfounded associations and causal estimands may not capture
natural aspects of exposure prevalence. Based on the PAF as effect measure,
we argue that in time-dependent settings causal effect measures and measures
of association must be regarded as distinct estimands with distinct interpreta-
tions. Moreover, disregarding the fundamental difference between time-fixed and
time-dependent data settings easily leads to misinterpretations.
A proper distinction between effect measures based on observable quantities
and those based on hypothetical ones helps to correctly interpret study results
and to draw the correct conclusions. The estimands defined for time-dependent
exposures based on observable quantities are often limited to a descriptive in-
terpretation. In contrast, estimands based on hypothetical outcomes allow for a
causal interpretation. However, an estimation of these quantities requires strong
assumptions. Moreover, they cannot describe observable phenomena as the time-
delay of exposure acquisition is not accounted for.
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Abbreviations
PAFo PAF as defined by [4] with observable variable
for time-fixed data settings
PAFc PAF as defined by [6] with counterfactual variables
for time-fixed data settings
PAFo(t) PAF for time-dependent exposures and competing risks -
defined with observable variables ( [3])
PAFc(t) PAF for time-dependent exposures and competing risks -
defined with counterfactual variables
P̂AF
naive
B (t) Unadjusted estimator of the PAF as proposed by [5]
P̂AF
IPW
B (t) Adjusted estimator of the PAF as proposed by [5]
P (D(t) = 1|E(t) = 0) Specific version of the CPF
(Death risk among unexposed as used in the definition of PAFo(t))
P (D0(t) = 1) Counterfactual death risk had all patients remained unexposed until time t
(Death risk among unexposed as used in the definition of PAFc(t))
F̂ naive
01
(t) Unadjusted estimated death risk among unexposed as proposed by [5]
Fˆ IPW
01
(t) Adjusted estimated death risk among unexposed as proposed by [5]
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Appendix
7.1 Definition of the counterfactual PAF as proposed by
Bekaert et al.
Bekaert et al. define an estimator of the PAF, which is based on estimated CIFs.
Formally, they propose at each time t
P̂AFB(t) =
Fˆ1(t)− Fˆ01(t)
Fˆ1(t)
. (11)
The quantity Fˆ1(t) is the ”estimated observed CIF of ICU mortality at time
t” ([5]). The quantity Fˆ01(t) is defined as the ”estimated counterfactual CIF
of ICU mortality at time t under the no-infection path” ([5]). The no-infection
path implies that the patient remained – possibly contrary to fact – infection-
free during the complete follow-up time (0, τ ]. For a detailed explanation of the
hypothetical infection paths we refer to [5].
The estimand F01(t) is formally defined by [5] as
F01(t) = P (T0 ≤ t, 0 = 1), (12)
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where T0 is the counterfactual event time under the no-infection path, i.e.
under the assumption that the patient would have remained – possibly contrary
to fact – infection-free, and 0 is the counterfactual outcome under the no-infection
path. We have 0 = 1 if the patient had died in the ICU under the no-infection
path and 0 = 2 if he had been discharged alive. Random censoring has not been
considered.
The estimand F01(t) is equivalent to P (D0(t) = 1). This is because D0(t) = 1
if the hypothetical event time is smaller or equal to the observation time t (T0 ≤ t)
and the hypothetical type of the event is death in the ICU (0 = 1).
Moreover, the estimand of Fˆ1(t) can be formally defined as
F1(t) = P (T ≤ t,  = 1), (13)
where T is the observed event time of death or discharge and  the observed type
of outcome, with  = 1 if the patient died in the ICU and  = 2 if having been
discharged alive. The same notation has been also used by [5]. We have that
P (D(t) = 1) = F1(t).
7.2 Proof of the equivalence of P̂AF o(t) and P̂AF
naive
B (t)
In the following we show that F̂ naive
01
(t) is equivalent to the estimator of the death
risk among unexposed, P̂ (D(t) = 1|E(t) = 0). Then, the equality of P̂AF o(t)
and P̂AF
naive
B (t) is a direct consequence.
7.2.1 Notations and definitions
Like commonly done in causal inference, [5] properly differentiate between ob-
servable and counterfactual outcomes. As introduced in the previous section, the
observable event time was defined by T and the hypothetical event time, had the
patient followed the no-infection path, by T0.
The no-infection path 0 = (01, ..., 0τ ) is a potential infection history of a
patient. The infection state of a patient is measured on a daily basis. At each
day within [1, τ ] the patients could potentially acquire an infection, given they
are still in the ICU at that day. The no-infection path is the potential path where
patients remain infection-free at every day during their ICU stay. A patient who
has been discharged (dead or alive) without an HAI remains infection-free until
the end of follow-up (τ), as an HAI can be only acquired in the ICU.
The observable event indicator was denoted by  (1 for death in the ICU, 2
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for discharge alive) and the hypothetical one under the no-infection path by 0.
The observable indicator of infection was At, which becomes one if the patient
was observed to acquire an HAI within (0, t].
The consistency assumption states that the hypothetical event time T0 and
outcome 0 of patients who were observed to be unexposed until the end of their
ICU stay is equal to their observed event time and state. Thus,
T0 = T and 0 = , if A(T ) = 0. (14)
The random variables T , A(t) and  observed for the specific patient i in the
study cohort are denoted by Ti, Ai(t) and i. The study cohort consists of n
patients.
The proof will be conducted by translating the estimator of Bekaert et al.
into an estimator based on counting process notation.
To simplify notation in the proof, we consider a competing risks process with
three-states, as shown in Figure 5, instead of the extended illness-death model.
By X(t) we denote the state occupied at time t, t ∈ [0, τ ], X(t) ∈ {0, 1, 2, 3}. The
defined counting process results from the extended illness-death model by disre-
garding States 4 and 5. This means that the patients entering State 1 remain in
State 1. We denote the transition-probabilities of this model by PklCR(0, t). Then,
P01CR(t) is simply the CIF of acquiring an infection. The transition probabilities
P02(0, t) and P03(0, t) are the same in both models (i.e. P02(0, t) = P02CR(0, t)
and P03(0, t) = P03CR(0, t)).
The following proof could be equivalently conducted with the counting process
defined by the extended illness-death model (Figure 1), since the CIF P01CR(t) of
the 3-state competing risks model (5) is equal to the sum P01(t) +P04(t) +P05(t)
of the extended illness-death model. Thus, we have that
P (D(t) = 1|E(t) = 0) = P03(0, t)
1− (P01(t) + P04(0, t) + P05(0, t))
=
P03(0, t)
1− P01CR(0, t)
=
P03CR(0, t)
1− P01CR(0, t)
.
Moreover, for each observation i, i = 1, ..., n, we introduce the following no-
tation which is based on the book by [11]):
Nkli(t) := 1(i makes a transition from k to l in [0, t])
Yki(t) := 1(i is in k at t−),
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where l, k ∈ {0, 1, 2, 3}, t− denotes the time shortly before t. In the ICU data
situations t− can be interpreted as t− 1, t in days since ICU admission.
Furthermore, we define
Nkl(t) :=
n∑
i=1
Nkli(t),
Yk(t) :=
n∑
i=1
Yki(t),
where Nkl(t) is the number of patients who made a transition from State k to
State l in [0, t] and Yk(t) is the number of patients in State k shortly before t (i.e.
at t−).
As [5], we assume complete follow-up. Then, the Aalen-Johansen estimators
of the transition probabilities of the 3-state competing risks model are simple
proportions ([22])
Pˆ0lCR(t) =
N0l(t)
n
,
with l ∈ {1, 2, 3}.
0: Admission
to the ICU 1: HAI
2: Discharge 
(without HAI)
3: Death 
(without HAI)
α03( t)
α01(t)
α02(t )
Figure 5: The competing risks model with hazard rates α01(t), α02(t), α03(t).
7.2.2 Proof of F̂ naive
01
(t) = P̂ (D(t) = 1|E(t) = 0)
Now, we show mathematically that F̂ naive
01
(t) is equivalent to P̂ (D(t) = 1|E(t) =
0). Based on the 3-states competing risks model defined in 3.1, we have
P̂ (D(t) = 1|E(t) = 0) = Pˆ03CR(t)
1− Pˆ01CR(t)
, (15)
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where Pˆ03CR(t) is the CIF of death without HAI by time t and Pˆ01CR(t) is the
estimated probability to be infected by time t. Since we do not consider States 4
and 5, Pˆ01CR(t) is an estimator of the CIF of infection.
First, we rewrite F̂ naive
01
(t) using our counting process notation. [5] defined
F̂ naive01 =
∑t
s=1 d01s
n0t
=
∑n
i=1 1(i(t) = 1)
∏t
s=1(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0))∑n
i=1
∏t
s=1(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0))
:=
∑n
i=1 1(i(t) = 1)× pi(t)∑n
i=1 pi(t)
,
with pi(t) :=
∏t
s=1(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0)).
Rewriting these quantities with our notation, we obtain
1(Ai(s) = 0) = 1−N01i(s)
1(i(s− 1) = 0) = 1(i(s−) = 0) = Y0i(s) + Y1i(s)
1(i(s− 1) 6= 0) = 1(i(s−) 6= 0) = 1− (Y0i(s) + Y1i(s)),
1(i(s) = 1) = N03i(s).
Then,
pi(t) =
∏
s≤t
((1−N01i(s))(Y0i(s) + Y1i(s)) + 1− (Y0i(s) + Y1i(s)))
=
∏
s≤t
(Y0i(s) + Y1i(s)−N01i(s)Y0i(s)−N01i(s)Y1i(s) + 1− Y0i(s)− Y1i(s))
=
∏
s≤t
(1−N01i(s)Y0i(s)−N01i(s)Y1i(s))
=
{
1, if N01i(t) = 0,
0, if N01i(t) 6= 0.
Since N01i(t) 6= 0, it follows that there exists s0 ≤ t (s0 is the time of infection)
such that N01i(s0) = 1 and Y0i(s0) = 1 and Y1i(s0) = 0. Thus, 1−N01i(s0)Y0i(s0)−
N01i(s0)Y1i(s0) = 1− 1− 0 = 0, implying that pi(t) = 0, since s0 ≤ t.
Therefore, we can simply write
pi(t) = 1−N01i(t).
It follows that
n0t =
n∑
i=1
pi(t) =
n∑
i=1
(1−N01i(t)) = n−N01(t)
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and
t∑
s=1
d01s =
n∑
i=1
N03i(t)(1−N01i(t))
=
n∑
i=1
N03i(t)−N01i(t)N03i(t),
=
n∑
i=1
N03i(t) = N03(t),
since N03i(t)N01i(t) = 0 for all t.
Summing up, we showed that
F̂ naive01 (t) =
∑t
s=1 d01s
n0t
=
N03(t)
n−N01(t) =
Pˆ03CR(1)
1− Pˆ01CR(t)
= P̂ (D(t) = 1|E(t) = 0).
7.3 Proof of the equivalence of P̂AF
IPW
B (t) = P̂AF c(t)
Now we show that the IPW-adjusted estimator
Fˆ IPW01 (t) =
∑n
i=1 1(i(t) = 1)Wi0t∑n
i=1Wi0t
,
with
Wi0t =
t∏
s=1
(1(Ai(s) = 0)1(i(s− 1) = 0) + 1(i(s− 1) 6= 0)
P (Ai(s) = 0|(i(s− 1), Ai(s− 1)) ,
is an inverse-probability of censoring weighted (IPCW) CIF which results from
the competing risks model (Figure 5) by treating infected patients as randomly
censored. Since this estimator is equivalent to Pˆ030(t) (see 7.3.1), it follows that
P̂AF
IPW
B (t) = P̂AFB(t).
7.3.1 The Horvitz-Thompson like estimator of the CIF
[35] showed the equivalence of the Kaplan-Meier estimator and a Horvitz Thomp-
son like estimator of the survival probability in a classic survival model (see ex-
emplary Figure 6).
Similarly, [36] showed that the CIF of a competing risks model in the presence
of random censoring can be estimated as a Horvitz-Thompson like estimator. This
is an IPCW version of the CIF ([36]).
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We consider the competing risks model of Section 3.1.1 that results from the
one in Figure 5 by treating infected patients as randomly censored instead of
accounting for infection as a competing risk to death and discharge without HAI
(Figure 2).
Formally, we denote the counting process defined by this model by XCR.
Moreover, we define by Tc a random censoring time and T
CR := min(T∗, Tc) with
T∗ being the (potentially due to random censoring unobserved) event time of
event type 2 or 3. Finally, TCRi is the observed time T
CR of patient i. (Thus,
N03i(T
CR
i ) = 1(Ti ≤ t, event of type 3 was observed for i).
For the event death (XCRTCR = 3) with the solely competing event discharge
alive and random censoring, the Horvitz-Thompson like estimator of the CIF is
Pˆ IPW03 (t) =
1
n
n∑
i=1
N03i(T
CR
i )
SˆTc(T
CR
i −)
,
where SˆTc is the estimated censoring distribution which could be for example
estimated by a Kaplan-Meier estimator.
In the following, we use the equivalence Pˆ030(t) = Pˆ
IPW
03 (t). However, the
random censoring time Tc is the (potentially unobserved) infection time denoted
by T01. This means that the censoring rate in Figure 2 is equal to the infection
rate in Figure 5.
7.3.2 Proof of Fˆ IPW
01
(t) = Pˆ030(t)
To begin with we consider the 3-state competing risks model defined by Fig-
ure 5. We denote by Ti the observed event time of patient i. Formally, Ti =
inf(t : Xi(t) ∈ {1, 2, 3}), where Xi(t) is the state occupied by patient i at time
t corresponding to the competing risks process in Figure 5. The hazard rates
of the counting process have also been defined in Figure 5. Thus, α01(t) is the
cause-specific hazard rate of moving from State 0 to State 1 at time t.
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We have
Wi0t =
∏
s≤t
pi(t)
P (Ai(s) = 0|i(s− 1), Ai(s− 1))
(1)
=
∏
s≤t
pi(t)
P (Ai(s) = 0|i(s− 1), Ai(s− 1) = 0)
(2)
=
∏
s≤t∧Ti
pi(t)
P (Ai(s) = 0|i(s− 1) = 0, Ai(s− 1) = 0)
=
∏
s≤t∧Ti
pi(t)
P (X˜i(s) 6= 1)|X˜i(s− 1) = 0)
=
∏
s≤t∧Ti
pi(t)
1− P (T ≤ s, X˜T = 1|T > s− ds)
=
∏
s≤t∧Ti
pi(t)
1− α01(s− ds)
(3)
=
pi(t)∏
s≤t∧Ti(1− α01(s− ds)ds)
=
pi(t)∏
s≤(t∧Ti)−ds(1− α01(s)ds)
(4)
=
pi(t)
S01((t ∧ Ti)− ds) :=
pi(t)
S01((t ∧ Ti)−) ,
where S01(t) := P (T01 > t), with T01 denoting the random survival time in
a standard survival model with α01(t) as the corresponding hazard rate. For
an illustration of the model see Figure 6. Equation (1) follows since pi(t) = 0
if there exists s0 ≤ t such that Ai(s0 − 1) = 1. Equation (2) follows from
P (Ai(s) = 0|(i(s − 1) 6= 0, Ai(s − 1) = 0)) = 1. Equation (3) is a result of
ds := 1 (as α01(s) is the daily rate of infection). Finally, equation (4) has been
shown by e.g. Aalen et al. [37] (Appendix A.1).
0: Admission
to the ICU 1: HAI
α01(t)
Figure 6: Classic survival model with hazard rate α01(t).
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In other words,
Wi0t =

0, if N01i(t) = 1,
1
S01(Ti−) , if N02i(t) +N03i(t) = 1
1
S01(t−) , if Y0i(t) = 1
S01(t−) can be estimated with the Kaplan-Meier estimator.
Bekaert et al. use a pooled logistic regression model to estimate α01(t). For
example, if we use the most basic form of this model (no adjustment for time or
and any covariates), we obtain the daily incidence rate of infection, i.e.
N01(τ)
Summed # of patient days
=
N01(τ)∑n
i=1 Ti
.
Furthermore, we have
Fˆ01(t) =
∑n
i=1 1(i(t) = 1)Wi0t∑n
i=1Wi0t
=
∑n
i=1N03i(t)Wi0t∑n
i=1Wi0t
with
n∑
i=1
Wi0t =
n∑
i=1
pi(t)
Sˆ01((t ∧ Ti)−)
=
n∑
i=1
N03i(t) +N02i(t)
Sˆ01(Ti−)
+
n∑
i=1
Y0i(t)
Sˆ01(t−)
.
Therefore, we can reformulate using the results of Section 7.3.1
Fˆ01(t) =
∑n
i=1
N03i(t)
Sˆ01(Ti−)∑n
i=1
N03i(t)+N02i(t)
Sˆ01(Ti−) +
∑n
i=1
Y0i(t)
Sˆ01(t−)
=
1
n
∑n
i=1
N03i(t)
Sˆ01(Ti−)
1
n
∑n
i=1
N03i(t)+N02i(t)
Sˆ01(Ti−) +
1
n
∑n
i=1
Y0i(t)
Sˆ01(t−)
=
Pˆ030(t)
Pˆ (TCR ≤ t) + Pˆ (TCR > t)
=
Pˆ030(t)
1
= Pˆ030(t).
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To sum up, we showed that without consideration of confounding Fˆ01(t) =
Pˆ030(t). Thus, P̂AF
IPW
B (t) = P̂AF c(t).
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